[Pyr3]-Amyloid beta-Protein (Human, 3 – 42)
| 4367-v | 0.5 mg | 290.00 EUR |
| 4367-1 | 2 x 0.5 mg | 480.00 EUR |
Synthetic Product (Trifluoroacetate Form)
Pyr – Phe – Arg – His – Asp – Ser – Gly – Tyr – Glu – Val – His – His – Gln – Lys – Leu – Val – Phe – Phe – Ala – Glu – Asp – Val – Gly – Ser – Asn – Lys – Gly – Ala – Ile – Ile – Gly – Leu – Met – Val – Gly – Gly – Val – Val -Ile – Ala
| (M.W. 4309.9) | C196H299N53O55S | [183449-57-2] |
The purity is guaranteed to be higher than 95% by HPLC
Major Neuritic Plaque Component in Alzheimer Disease
References:
- T.C. Saido, T. Iwatsubo, D.M.A. Mann, H. Shimada, Y. Ihara, and S. Kawashima, Neuron, 14, 457 (1995) (Pharmacol.; Dominant Deposition in Senile Plaques)
- T. Iwatsubo, T.C. Saido, D.M.A. Mann, V.M.-Y. Lee, and J.Q. Trojanowski, Am. J. Pathol, 149, 1823 (1996) (Histochem.; Distribution in brains of patients)
- Y.-M. Kuo, M.R. Emmerling, A.S. Woods, R.J. Cotter, and A.E. Roher, Biochem. Biophys. Res. Commun., 237, 188 (1997) (Pharmacol.; Form in Neuritic Plaques and Vascular Amyloid Deposits)
